Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Erica Dahl Warlick
Modified Reduced Intensity Conditioning (RIC) of HLA-Haploidentical Related Hematopoietic Cell Transplantation (HAPLO-HCT) for Patients With Hematological Malignancies: Interim Analysis of an Age- And Risk-Adapted Phase II Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Peripheral Blood Progenitor Cell (PBPC) Transplantation From Haploidentical Donors Following Reduced Intensity Conditioning (RIC) for High-Risk Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab From HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients With Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Post-Transplant Cyclophosphamide (PTCy)-Based Haploidentical (Haplo) Donor vs. Calcineurin-Inhibitor (CNI)-Based Matched Related Donor (MRD) Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (ALLO) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients With Hematologic Malignancies: A Monocenter Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Health-Related Quality of Life in Patients Receiving Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
A Reduced-Intensity Conditioning Regimen for Patients With Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Haploidentical Hematopoietic Stem Cell Transplantation Without in Vitro T-Cell Depletion for the Treatment of Hematological Malignancies
Bone Marrow Transplantation
Transplantation
Hematology
